First Time Loading...

Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.67 DKK -1.53%
Updated: Jun 6, 2024

Bioporto A/S
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioporto A/S
Cost of Revenue Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
SANION

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bioporto A/S
CSE:BIOPOR
Cost of Revenue
-kr10.3m
CAGR 3-Years
0%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Genmab A/S
CSE:GMAB
Cost of Revenue
-kr411m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Cost of Revenue
-kr23.8m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Cost of Revenue
-€47.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Cost of Revenue
-kr2.6B
CAGR 3-Years
-25%
CAGR 5-Years
-53%
CAGR 10-Years
-18%
Saniona AB
STO:SANION
Cost of Revenue
-kr52.7m
CAGR 3-Years
19%
CAGR 5-Years
9%
CAGR 10-Years
N/A

See Also

What is Bioporto A/S's Cost of Revenue?
Cost of Revenue
-10.3m DKK

Based on the financial report for Mar 31, 2024, Bioporto A/S's Cost of Revenue amounts to -10.3m DKK.

What is Bioporto A/S's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-3%

Over the last year, the Cost of Revenue growth was -2%.